eAppendix -- New Approaches to Measuring Value in Oncology Therapy
Appendix B -- Value of Survival Gains in Chronic Myeloid Leukemia
Appendix A -- Value of Survival Gains in Chronic Myeloid Leukemia
Participating Faculty: New Approaches to Measuring Value in Oncology Therapy
Coverage and Use of Cancer Therapies in the Treatment of Chronic Myeloid Leukemia
Dynamic Cost-Effectiveness of Oncology Drugs
The Option Value of Innovative Treatments in the Context of Chronic Myeloid Leukemia
Value of Survival Gains in Chronic Myeloid Leukemia
Although clinical trial data have quantified patient survival gains associated with tyrosine kinase inhibitors in chronic myeloid leukemia, the overall value of these benefits is unknown.
